Graham Capital Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-10,242
Closed -$706K – 1440
2024
Q1
$706K Buy
+10,242
New +$691K 0.01% 525
2023
Q3
– Sell
-52,561
Closed -$2.65M – 1344
2023
Q2
$2.65M Sell
52,561
-12,343
-19% -$657K 0.08% 171
2023
Q1
$3.54M Buy
64,904
+2,541
+4% +$148K 0.11% 129
2022
Q4
$3.9M Buy
62,363
+13,144
+27% +$872K 0.12% 92
2022
Q3
$3.47M Buy
49,219
+10,865
+28% +$749K 0.14% 97
2022
Q2
$2.17M Sell
38,354
-830
-2% -$45.5K 0.09% 185
2022
Q1
$2.45M Buy
+39,184
New +$2.11M 0.08% 109

Other funds holding AXNX

Graham Capital Management's AXNX Position: Q2 2024 in Review

Graham Capital Management sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2024, closing a stake of 10,242 shares — an estimated $706K sold.

Graham Capital Management first reported a position in AXNX in Q1 2022 and held it in 7 quarters. The position peaked at $3.9M in Q4 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2024.

  • Graham Capital Management reported no remaining Axonics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Graham Capital Management sold 10,242 Axonics, Inc. Common Stock shares in Q2 2024, an estimated $706K.
  • Graham Capital Management first reported a position in Axonics, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • Graham Capital Management's Axonics, Inc. Common Stock position peaked at $3.9M in Q4 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2024.

Based on Graham Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.